AHB-171 treatment for chronic hepatitis B
Treatments studied
Part of Digestive system, Immune system & allergy, Infections, Lungs & breathing clinical trials.
This study tests whether a new drug called AHB-171 can help treat chronic hepatitis B (a long-term liver infection). You would receive the drug by injection under your skin and be monitored to see if it helps reduce the hepatitis B virus and improves liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic hepatitis B that has been confirmed for at least 6 months
- You are between 18 and 65 years old and in generally good health
- Your liver disease is stable—no signs of advanced scarring, cirrhosis, or liver cancer
- You have not had certain other serious infections, liver diseases, or organ transplants
- You agree to use effective birth control during the study and avoid certain other medications or vaccines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection called AHB-137 for people with chronic hepatitis B. It aims to see if the drug is safe and helps control the virus.
This study tests a new injection called AHB-137 in people with chronic hepatitis B who have never received antiviral treatment. The goal is to see if it can help reduce the hepatitis B virus in the body and improve liver health.
This study tests a new injection called AHB-137 combined with other hepatitis B drugs. It aims to see if the combination can better control the virus in people with chronic hepatitis B who are already on antiviral pills.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
This trial tests a new investigational drug called AHB-171 for people with chronic hepatitis B who are already stable on standard antiviral therapy. It aims to see if the drug is safe and may help control the virus better.
This trial tests an experimental drug called AHB-171 for people with chronic hepatitis B. It aims to see if the drug is safe and how well it works. You may be able to join if you have had hepatitis B for at least 6 months and meet other health requirements.
Hear when a new Hepatitis B, Chronic (CHB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.